Reid G. Hoffman - 02 Aug 2021 Form 4 Insider Report for Hippo Holdings Inc. (HIPO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Aug 2021, 16:49:46 UTC
Prior SEC filing
11 Jun 2021
Next SEC filing
12 Aug 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Cohen as attorney-in-fact for Reid Hoffman

Key filing fact

Reid G. Hoffman filed Form 4 for Hippo Holdings Inc. (HIPO) on 03 Aug 2021.

Key facts

  • This page summarizes Reid G. Hoffman's Form 4 filing for Hippo Holdings Inc. (HIPO).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Aug 2021, 16:49.

Change

  • Previous filing in this sequence was filed on 11 Jun 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIPO transaction

Common Stock

Options Exercise

Transaction value
Shares
+5,630,000
Change %
Price
Shares after
5,630,000
Date
02 Aug 2021
Ownership
See Footnote
Footnotes
F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIPO transaction Derivative

Class B ordinary shares

Options Exercise

Transaction value
Shares
-5,630,000
Change %
-100%
Price
Shares after
0
Date
02 Aug 2021
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
5,630,000
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Reid G. Hoffman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

75% of such shares are subject to vesting in tranches of 25% if the volume weighted average price of the Issuer's shares of Common Stock equals or exceeds $12.50, $15.00, or $20.00, respectively, for any 20 trading days within a 30 trading day period on or prior to the tenth anniversary of the business combination of Reinvent Technology Partners Z (the former name of the Issuer) ("RTPZ") and Hippo Enterprises Inc. (the "Business Combination"). On August 2, 2031, any unvested shares will automatically vest. In the event the Issuer completes a transaction that results in a change of control, all unvested shares will vest immediately prior to the closing of such transaction.

Footnote F2

On August 2, 2021, RTPZ consummated the Business Combination. Pursuant to the Business Combination, RTPZ domesticated as a Delaware corporation and changed its name to "Hippo Holdings, Inc.", and each RTPZ Class B ordinary share was automatically converted into the right to receive one share of the Issuer's common stock. The reporting person resigned as a director of the Issuer upon consummation of the Business Combination.

Footnote F3

The securities reported herein are directly held by Reinvent Sponsor Z LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .